Jespersen, L. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734-744. doi:10.1093/eurheartj/ehr331.
Joo Myung Lee, et al. Integrated Physiologic Assessment of Ischemic Heart Disease in Real-World Practice Using Index of Microcirculatory Resistance and Fractional Flow Reserve. Circulation. Nov 2015; 8 (11).
Filippo Crea, et al. Coronary microvascular dysfunction: an update. Eur Heart J 35(17): 1101-1111, 2014.
Taqueti et al. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options. JACC 2018.
Gautam Kumar, et. al. Real world validation of the nonhyperemic index of coronary artery stenosis severity—Resting full-cycle ratio— RE-VALIDATE. Catheter Cardiovasc Interv. 2019;1–6
Tonino et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J. Am. Coll. Cardiol. 2010; 55; 2816-2821
Ford, T.J. et al. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA). J Am Coll Cardiol Intv. 2020;13(1):33-45.
Gdowski M, et al. Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data. JAHA. 2020; 9:e014954.
Lee, B. et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131:1054–1060.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.